Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-02 10:21 am Purchase |
2022-08-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 713,964 5.100% |
713,964 (New Position) |
Filing History |
| 2022-09-02 10:18 am Purchase |
2022-08-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Soleus Capital Master Fund, L.P. | 498,279 5.000% |
498,279 (New Position) |
Filing History |
| 2022-09-01 09:00 am Purchase |
2022-08-29 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 646,411 5.100% |
646,411 (New Position) |
Filing History |
| 2022-05-18 06:06 am Purchase |
2022-05-16 | 13G | Celcuity Inc. CELC |
Soleus Capital Master Fund, L.P. | 948,389 6.100% |
948,389 (New Position) |
Filing History |
| 2022-04-29 5:01 pm Purchase |
2022-04-28 | 13G | CVRx, Inc. CVRX |
Soleus Capital Master Fund, L.P. | 1,044,040 5.100% |
1,044,040 (New Position) |
Filing History |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | EDAP TMS S.A. EDAP |
Soleus Capital Master Fund, L.P. | 3,148,609 9.400% |
1,324,043 (+72.57%) |
Filing History |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 2,310,521 9.600% |
454,175 (+24.47%) |
Filing History |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Soleus Capital Master Fund, L.P. | 2,295,100 5.800% |
209,603 (+10.05%) |
Filing History |
| 2022-01-27 4:30 pm Purchase |
2022-01-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 48,561 5.400% |
48,561 (New Position) |
Filing History |
| 2021-12-20 5:01 pm Purchase |
2021-12-14 | 13G | Apollo Endosurgery, Inc. APEN |
Soleus Capital Master Fund, L.P. | 2,085,497 5.300% |
2,085,497 (New Position) |
Filing History |
| 2021-04-27 5:41 pm Purchase |
2021-04-23 | 13G | EDAP TMS S.A. EDAP |
Soleus Capital Master Fund, L.P. | 1,824,566 5.500% |
1,824,566 (New Position) |
Filing History |
| 2021-02-23 4:11 pm Purchase |
2021-01-19 | 13G | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 1,856,346 7.800% |
1,856,346 (New Position) |
Filing History |